Abstract
As the epidemic of obesity continues to infest the world population at alarming proportions, researchers have started to focus on the endocrine aspect of its basic unit: the adipocyte. The last two decades have proved beneficial in understanding the impact of adipocytes, specifically the metabolic influences of its hormones, the adipocytokines. This review focuses on our current understanding of leptin and adiponectin, two of the most studied and established adipocytokines. Patents regarding leptin and adiponectin are highlighted.
Keywords: Leptin, adiponectin, patents
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Title: Advancement in Obesity Management: Leptin and Adiponectin Patents
Volume: 2 Issue: 3
Author(s): Nasser M. Al-Daghri
Affiliation:
Keywords: Leptin, adiponectin, patents
Abstract: As the epidemic of obesity continues to infest the world population at alarming proportions, researchers have started to focus on the endocrine aspect of its basic unit: the adipocyte. The last two decades have proved beneficial in understanding the impact of adipocytes, specifically the metabolic influences of its hormones, the adipocytokines. This review focuses on our current understanding of leptin and adiponectin, two of the most studied and established adipocytokines. Patents regarding leptin and adiponectin are highlighted.
Export Options
About this article
Cite this article as:
Al-Daghri M. Nasser, Advancement in Obesity Management: Leptin and Adiponectin Patents, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2008; 2 (3) . https://dx.doi.org/10.2174/187221408786241793
DOI https://dx.doi.org/10.2174/187221408786241793 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Proteasome Modulation in Brain: A New Target for Anti-Aging Drugs?
Central Nervous System Agents in Medicinal Chemistry Thyroid Disorders in Chronic Heart Failure: From Prognostic Set-up to Therapeutic Management
Endocrine, Metabolic & Immune Disorders - Drug Targets Role of Methylene Blue in Trauma Neuroprotection and Neuropsychiatric Diseases
CNS & Neurological Disorders - Drug Targets Quality of Life in Dementia Sufferers: The Role of Diet and Exercise
Current Alzheimer Research Editorial (Thematic Issue: Ceramics, Nanotubes, Advanced Materials: Theoretical and Experimental Structure-Property Relationships Part IV)
Current Physical Chemistry The Double Roles of the Prostaglandin E<sub>2</sub> EP2 Receptor in Intracerebral Hemorrhage
Current Drug Targets Desmopressin 30 Years in Clinical Use: A Safety Review
Current Drug Safety Schizophrenia: A Systematic Review of the Disease State, Current Therapeutics and their Molecular Mechanisms of Action
Current Medicinal Chemistry Macrophage Colony-Stimulating Factor (M-CSF) in Plasma and CSF of Patients with Mild Cognitive Impairment and Alzheimers Disease
Current Alzheimer Research Decreased Plasma Level of Lipoprotein Lipase Predicted Verbal Disfluency in Chinese Type 2 Diabetes Mellitus Patients with Early Cognitive Deficits
Current Alzheimer Research Chloride Channels − New Targets for the Prevention of Stroke
Current Vascular Pharmacology Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments
Recent Patents on CNS Drug Discovery (Discontinued) Does Intraneuronal Accumulation of Carboxyl-terminal Fragments of the Amyloid Precursor Protein Trigger Early Neurotoxicity in Alzheimer’s Disease?
Current Alzheimer Research Functional Role of Lipoprotein Receptors in Alzheimers Disease
Current Alzheimer Research The Co-agonist Site of NMDA-glutamate Receptors: A Novel Therapeutic Target for Age-related Cognitive Decline
Current Pharmaceutical Design Cushing's Syndrome and Steroid Dementia
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery A Scientometrics Analysis and Visualization of Depressive Disorder
Current Neuropharmacology Eigenanatomy on Fractional Anisotropy Imaging Provides White Matter Anatomical Features Discriminating Between Alzheimer’s Disease and Late Onset Bipolar Disorder
Current Alzheimer Research Effects of Memantine on Event-Related Potentials in Alzheimer’s Disease Under Donepezil Treatment
Neuroscience and Biomedical Engineering (Discontinued) Lipid-Lowering Therapies for Atherosclerosis: Statins, Fibrates, Ezetimibe and PCSK9 Monoclonal Antibodies
Current Medicinal Chemistry